{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:14:17Z","timestamp":1789665257040,"version":"4.0.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"UD Faculty of Medicine Research Foundation","award":["1G3D1YCSDK12 246"],"award-info":[{"award-number":["1G3D1YCSDK12 246"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.autrev.2014.08.011","type":"journal-article","created":{"date-parts":[[2014,8,23]],"date-time":"2014-08-23T09:35:33Z","timestamp":1408786533000},"page":"1211-1219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Four dermatomyositis-specific autoantibodies\u2014anti-TIF1\u03b3, anti-NXP2, anti-SAE and anti-MDA5\u2014in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort"],"prefix":"10.1016","volume":"13","author":[{"given":"Levente","family":"Bodoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Nagy-Vincze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Griger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Betteridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3n\u00e9","family":"Sz\u00f6ll\u0151si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Dank\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2014.08.011_bb0005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.011_bb0010","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","article-title":"Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria","volume":"28","author":"Mastaglia","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2014.08.011_bb0015","article-title":"Juvenile dermatomyositis: a 20-year retrospective analysis of treatment and clinical outcomes","author":"Sun","year":"2014","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.autrev.2014.08.011_bb0020","article-title":"Dermatomyositis, polymyositis and immune-mediated necrotising myopathies","author":"Luo","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2014.08.011_bb0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.autrev.2014.01.016","article-title":"Diagnosis and classification of sporadic inclusion body myositis (sIBM)","volume":"13","author":"Catal\u00e1n","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.011_bb0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/CND.0000000000000038","article-title":"Clinically amyopathic dermatomyositis: analysis of a monocentric cohort","volume":"15","author":"Neri","year":"2014","journal-title":"J Clin Neuromuscul Dis"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.011_bb0035","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/BOR.0b013e3283317fa5","article-title":"Paraneoplastic myopathy","volume":"21","author":"Dank\u00f3","year":"2009","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.011_bb0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.autrev.2011.05.013","article-title":"Pathogenesis and therapies of immune-mediated myopathies","volume":"11","author":"Dalakas","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2014.08.011_bb0045","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.autrev.2014.01.017","article-title":"Diagnosis and classification of granulomatous myositis","volume":"13","author":"Prieto-Gonz\u00e1lez","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2014.08.011_bb0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.autrev.2014.01.018","article-title":"Eosinophilic myositis: an updated review","volume":"13","author":"Selva-O'Callaghan","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.011_bb0055","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","article-title":"Novel aspects of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights","volume":"6","author":"Mahler","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.011_bb0060","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/SCS.0000000000000510","article-title":"Idiopathic orbital myositis","volume":"25","author":"Yan","year":"2014","journal-title":"J Craniofac Surg"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.011_bb0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5692\/clinicalneurol.48.36","article-title":"Case of eosinophilic myositis in continuum from localized nodular myositis","volume":"48","author":"Matsuse","year":"2008","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.autrev.2014.08.011_bb0070","doi-asserted-by":"crossref","first-page":"258","DOI":"10.12659\/AJCR.890466","article-title":"Cavitating lung lesion as a manifestation of inflammatory tumor (pseudotumor) of the lung: a case report and literature review","volume":"15","author":"Michaelides","year":"2014","journal-title":"Am J Case Rep"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.011_bb0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.autrev.2013.08.005","article-title":"A review on the association between inflammatory myopathies and vaccination","volume":"13","author":"St\u00fcbgen","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.011_bb0080","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0387-7604(96)00049-6","article-title":"Infantile myositis presenting in the neonatal period","volume":"18","author":"Vajsar","year":"1996","journal-title":"Brain Dev"},{"key":"10.1016\/j.autrev.2014.08.011_bb0085","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1053\/berh.2002.0261","article-title":"Idiopathic inflammatory myopathies\u2014myositis","volume":"16","author":"Dorph","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.011_bb0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0090-1229(89)90130-X","article-title":"Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides","volume":"50","author":"Takeda","year":"1989","journal-title":"Clin Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.011_bb0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08916930600623791","article-title":"In patients with antisynthetase syndrome the occurrence of anti-Ro\/SSA antibodies causes a more severe interstitial lung disease","volume":"39","author":"La Corte","year":"2006","journal-title":"Autoimmunity"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.011_bb0100","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00296-009-0884-9","article-title":"Characteristics of interstitial lung disease in SS-A positive\/Jo-1 positive inflammatory myopathy patients","volume":"29","author":"V\u00e1ncsa","year":"2009","journal-title":"Rheumatol Int"},{"issue":"10","key":"10.1016\/j.autrev.2014.08.011_bb0105","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/1529-0131(200110)44:10<2367::AID-ART400>3.0.CO;2-I","article-title":"Increased prevalence of autoantibodies to Ku antigen in African American versus white patients with systemic lupus erythematosus","volume":"44","author":"Wang","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.011_bb0110","first-page":"563","article-title":"Clinical and serological associations of anti-Ku antibody","volume":"26","author":"Cooley","year":"1999","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.011_bb0115","first-page":"1393","article-title":"Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients","volume":"29","author":"Franceschini","year":"2002","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.011_bb0120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.011_bb0125","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2169\/internalmedicine.51.6566","article-title":"Characterization of dermatomyositis with coexistence of anti-Jo-1 and anti-SRP antibodies","volume":"51","author":"Sugie","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2014.08.011_bb0130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00002281-200011000-00001","article-title":"Update on myositis-specific and myositis-associated autoantibodies","volume":"12","author":"Targoff","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2014.08.011_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome","author":"Lega","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2014.08.011_bb0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2013.08.008","article-title":"Complement-mediated muscle cell lysis: a possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM)","volume":"264","author":"Rojana-udomsart","year":"2013","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.011_bb0145","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MD.0000000000000028","article-title":"Anti-HMGCR Autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin","volume":"93","author":"Allenbach","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.011_bb0150","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2014.08.011_bb0155","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.autrev.2013.07.001","article-title":"Statin-induced necrotizing myositis\u2014a discrete autoimmune entity within the \u201cstatin-induced myopathy spectrum\u201d","volume":"12","author":"Hamann","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.011_bb0160","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/BOR.0b013e328358bd85","article-title":"Myositis autoantibodies","volume":"24","author":"Casciola-Rosen","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2014.08.011_bb0165","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/01.bor.0000434664.37880.ac","article-title":"The diagnostic utility of autoantibodies in adult and juvenile myositis","volume":"25","author":"Tansley","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2014.08.011_bb0170","first-page":"S787","article-title":"Sera with autoantibodies to the MJ antigen react with NXP2","volume":"56","author":"Targoff","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.08.011_bb0175","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","article-title":"Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study","volume":"147","author":"Hamaguchi","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2014.08.011_bb0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2014.08.011_bb0190","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20035","article-title":"Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies","volume":"62","author":"Rider","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2014.08.011_bb0195","series-title":"Muscles: testing and function","author":"Kendall","year":"1993"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2014.08.011_bb0200","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.autrev.2014.01.022","article-title":"Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review","volume":"13","author":"Mahler","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.011_bb0205","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","article-title":"Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes","volume":"9","author":"Koneig","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.011_bb0210","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2012.06.006","article-title":"Hierarchical cluster and survival analyses of antisynthetase-syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity","volume":"12","author":"Hervier","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2014.08.011_bb0215","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.autrev.2012.01.006","article-title":"Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome","volume":"11","author":"Marie","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.011_bb0220","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e318260977c","article-title":"Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature","volume":"91","author":"Labirua-Iturburu","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.011_bb0225","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.autrev.2011.09.007","article-title":"Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in anti-Jo1 antibody-positive polymyositis patients: a single center study and review of the literature","volume":"11","author":"Ingegnoli","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.08.011_bb0230","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.08.011_bb0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","article-title":"Identification of a novel autoantibody reactive with 155 and 140kDa nuclear proteins in patients with dermatomyositis: an association with malignancy","volume":"46","author":"Kaji","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2014.08.011_bb0240","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical associations of autoantibodies to a p155\/140kDa doublet protein in juvenile dermatomyositis","volume":"47","author":"Gunawardena","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2014.08.011_bb0245","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2340\/00015555-0955","article-title":"Anti-p155\/140 antibody-positive dermatomyositis with metastasis originating from an unknown site","volume":"91","author":"Ohashi","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.autrev.2014.08.011_bb0250","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","article-title":"Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis","volume":"49","author":"Hoshino","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2014.08.011_bb0255","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11926-011-0169-7","article-title":"Malignancy in myositis","volume":"13","author":"Zahr","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2014.08.011_bb0260","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2340\/00015555-1550","article-title":"TIF1\u03b3-overexpressing, highly progressive endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associated anti-p155\/140 autoantibody","volume":"93","author":"Kasuya","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.autrev.2014.08.011_bb0265","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","article-title":"Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy","volume":"71","author":"Ichimura","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.08.011_bb0270","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar3822","article-title":"Anti-MJ\/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis\/dermatomyositis","volume":"14","author":"Ceribelli","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.08.011_bb0275","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","article-title":"Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis","volume":"60","author":"Gunawardena","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.08.011_bb0280","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.3899\/jrheum.090461","article-title":"Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein","volume":"36","author":"Espada","year":"2009","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.011_bb0285","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.autrev.2011.10.024","article-title":"Hematological malignancy associated with polymyositis and dermatomyositis","volume":"11","author":"Marie","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.08.011_bb0290","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2036.2009.04190.x","article-title":"The gastrointestinal complications of myositis","volume":"31","author":"Ebert","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2014.08.011_bb0295","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s003840050234","article-title":"Polymyositis of the skeletal muscles as an extraintestinal complication in quiescent ulcerative colitis","volume":"14","author":"Voigt","year":"1999","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.autrev.2014.08.011_bb0300","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/BOR.0b013e328331927e","article-title":"Juvenile dermatomyositis: extra-muscular manifestations and their management","volume":"21","author":"Lowry","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2014.08.011_bb0305","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/ard.2008.097162","article-title":"Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis","volume":"68","author":"Betteridge","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.08.011_bb0310","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1002\/art.22862","article-title":"Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis","volume":"56","author":"Betteridge","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.08.011_bb0315","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jim.2012.07.019","article-title":"Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort","volume":"384","author":"Tarricone","year":"2012","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.autrev.2014.08.011_bb0320","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/08916934.2012.755958","article-title":"Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients","volume":"46","author":"Muro","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2014.08.011_bb0325","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.08.011_bb0330","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","article-title":"Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease","volume":"23","author":"Sato","year":"2013","journal-title":"Mod Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:12:33Z","timestamp":1761599553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214001554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":65,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1568997214001554"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.08.011","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Four dermatomyositis-specific autoantibodies\u2014anti-TIF1\u03b3, anti-NXP2, anti-SAE and anti-MDA5\u2014in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}